Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2
Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2
About this item
Full title
Author / Creator
Williamson, Brandi N. , Feldmann, Friederike , Schwarz, Benjamin , Meade-White, Kimberly , Porter, Danielle P. , Schulz, Jonathan , van Doremalen, Neeltje , Leighton, Ian , Yinda, Claude Kwe , Pérez-Pérez, Lizzette , Okumura, Atsushi , Lovaglio, Jamie , Hanley, Patrick W. , Saturday, Greg , Bosio, Catharine M. , Anzick, Sarah , Barbian, Kent , Cihlar, Tomas , Martens, Craig , Scott, Dana P. , Munster, Vincent J. and de Wit, Emmie
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Effective therapies to treat coronavirus disease 2019 (COVID-19) are urgently needed. While many investigational, approved, and repurposed drugs have been suggested as potential treatments, preclinical data from animal models can guide the search for effective treatments by ruling out those that lack efficacy in vivo. Remdesivir (GS-5734) is a nucl...
Alternative Titles
Full title
Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2
Authors, Artists and Contributors
Author / Creator
Feldmann, Friederike
Schwarz, Benjamin
Meade-White, Kimberly
Porter, Danielle P.
Schulz, Jonathan
van Doremalen, Neeltje
Leighton, Ian
Yinda, Claude Kwe
Pérez-Pérez, Lizzette
Okumura, Atsushi
Lovaglio, Jamie
Hanley, Patrick W.
Saturday, Greg
Bosio, Catharine M.
Anzick, Sarah
Barbian, Kent
Cihlar, Tomas
Martens, Craig
Scott, Dana P.
Munster, Vincent J.
de Wit, Emmie
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7486271
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7486271
Other Identifiers
ISSN
0028-0836
E-ISSN
1476-4687
DOI
10.1038/s41586-020-2423-5
